
    
      This is a multicenter trial evaluated the diagnostic ability of 3.0 T contrast-enhanced
      whole-heart coronary MRA to detect significant coronary artery stenosis among patients with
      suspected CAD.

      A total of 272 patients will be prospectively enrolled from 8 cities in China.
    
  